These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

361 related articles for article (PubMed ID: 24212967)

  • 21. Epigenetic Regulation of Angiogenesis in Development and Tumors Progression: Potential Implications for Cancer Treatment.
    Aspriţoiu VM; Stoica I; Bleotu C; Diaconu CC
    Front Cell Dev Biol; 2021; 9():689962. PubMed ID: 34552922
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Deciphering the epigenetic network in cancer radioresistance.
    Cabrera-Licona A; Pérez-Añorve IX; Flores-Fortis M; Moral-Hernández OD; González-de la Rosa CH; Suárez-Sánchez R; Chávez-Saldaña M; Aréchaga-Ocampo E
    Radiother Oncol; 2021 Jun; 159():48-59. PubMed ID: 33741468
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Epigenetic modification in chromatin machinery and its deregulation in pediatric brain tumors: Insight into epigenetic therapies.
    Maury E; Hashizume R
    Epigenetics; 2017 May; 12(5):353-369. PubMed ID: 28059591
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The growing role of epigenetics in childhood cancers.
    Panditharatna E; Filbin MG
    Curr Opin Pediatr; 2020 Feb; 32(1):67-75. PubMed ID: 31895160
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Targeting Chromatin Remodeling for Cancer Therapy.
    Kaur J; Daoud A; Eblen ST
    Curr Mol Pharmacol; 2019; 12(3):215-229. PubMed ID: 30767757
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Histone modifications: Targeting head and neck cancer stem cells.
    Le JM; Squarize CH; Castilho RM
    World J Stem Cells; 2014 Nov; 6(5):511-25. PubMed ID: 25426249
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Altered primary chromatin structures and their implications in cancer development.
    Ferraro A
    Cell Oncol (Dordr); 2016 Jun; 39(3):195-210. PubMed ID: 27007278
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Epigenetic regulation of cancer stem cell and tumorigenesis.
    Zhu K; Xie V; Huang S
    Adv Cancer Res; 2020; 148():1-26. PubMed ID: 32723561
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Epigenetics in cancer.
    Sharma S; Kelly TK; Jones PA
    Carcinogenesis; 2010 Jan; 31(1):27-36. PubMed ID: 19752007
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Stem cell programs in cancer initiation, progression, and therapy resistance.
    Huang T; Song X; Xu D; Tiek D; Goenka A; Wu B; Sastry N; Hu B; Cheng SY
    Theranostics; 2020; 10(19):8721-8743. PubMed ID: 32754274
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Epigenetic mechanisms regulating fate specification of neural stem cells.
    Namihira M; Kohyama J; Abematsu M; Nakashima K
    Philos Trans R Soc Lond B Biol Sci; 2008 Jun; 363(1500):2099-109. PubMed ID: 18375376
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Epigenetic modifications in cancer.
    Kanwal R; Gupta S
    Clin Genet; 2012 Apr; 81(4):303-11. PubMed ID: 22082348
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Epigenetic and Immune Regulation of Colorectal Cancer Stem Cells.
    Paschall AV; Liu K
    Curr Colorectal Cancer Rep; 2015 Dec; 11(6):414-421. PubMed ID: 30655730
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Molecular Mechanisms of Epigenetic Regulators as Activatable Targets in Cancer Theranostics.
    Li Y; Li Z; Zhu WG
    Curr Med Chem; 2019; 26(8):1328-1350. PubMed ID: 28933282
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Epigenetic dysregulation in hepatocellular carcinoma: an up-to-date review.
    Nakamura M; Chiba T; Kanayama K; Kanzaki H; Saito T; Kusakabe Y; Kato N
    Hepatol Res; 2019 Jan; 49(1):3-13. PubMed ID: 30238570
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Epigenetic regulation of stemness maintenance in the neurogenic niches.
    Montalbán-Loro R; Domingo-Muelas A; Bizy A; Ferrón SR
    World J Stem Cells; 2015 May; 7(4):700-10. PubMed ID: 26029342
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Colon cancer stemness as a reversible epigenetic state: Implications for anticancer therapies.
    Vincent A; Ouelkdite-Oumouchal A; Souidi M; Leclerc J; Neve B; Van Seuningen I
    World J Stem Cells; 2019 Nov; 11(11):920-936. PubMed ID: 31768220
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Targeting cellular memory to reprogram the epigenome, restore potential, and improve somatic cell nuclear transfer.
    Eilertsen KJ; Power RA; Harkins LL; Misica P
    Anim Reprod Sci; 2007 Mar; 98(1-2):129-46. PubMed ID: 17166676
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Emerging roles of Myc in stem cell biology and novel tumor therapies.
    Yoshida GJ
    J Exp Clin Cancer Res; 2018 Jul; 37(1):173. PubMed ID: 30053872
    [TBL] [Abstract][Full Text] [Related]  

  • 40. REST and CoREST are transcriptional and epigenetic regulators of seminal neural fate decisions.
    Qureshi IA; Gokhan S; Mehler MF
    Cell Cycle; 2010 Nov; 9(22):4477-86. PubMed ID: 21088488
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 19.